Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological TherapyUlrich Keilholz, Michael B. Atkins, Peter P. Lee et al.|Journal of Immunotherapy|2002Cited by 299
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy BiomarkersLisa H. Butterfield, Mary L. Disis, A. Karolina Palucka et al.|Clinical Cancer Research|2011Cited by 109
CD84 is a regulator of the immunosuppressive microenvironment in multiple myelomaHadas Lewinsky, Idit Shachar, Emine Gulsen Gunes et al.|JCI Insight|2021Cited by 64
CD84 is a regulator of the immunosuppressive microenvironment in multiple myelomaHadas Lewinsky, Idit Shachar, Emine Gulsen Gunes et al.|JCI Insight|2023Cited by 6
Long-term clinical outcomes with <i>Clostridium butyricum</i> MIYAIRI 588 (CBM588) and TOPOSCORE assessment in patients receiving immune checkpoint inhibitor (ICI)-based combinations for metastatic renal cell carcinoma (mRCC).Sumanta Kumar Pal, Nazli Dizman, Hedyeh Ebrahimi et al.|Journal of Clinical Oncology|2026Cited by 0